Confirmation of the involvement of the ADAM17/NOTCH pathway in SSc comes from studies that have used inhibitors, such as siRNAs directed against Notch genes, which prevented the development of fibrotic tissue in the mouse model [65]. Here, ADAM17 is linked to systemic sclerosis.